To determine whether methylation directly contributes to CHD5 silencing, we treated two RCC cell lines (HH244 and RCC98) with DNA methyltransferase inhibitor Aza, alone or in combination with histone deacetylase inhibitor TSA. Here, CHD5 is linked to renal cell carcinoma.